Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes
Han Cheng, Xiaokun Gang, Yujia Liu, et al.
AJP Endocrinology and Metabolism (2019) Vol. 318, Iss. 5, pp. E750-E764
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The redox language in neurodegenerative diseases: oxidative post-translational modifications by hydrogen peroxide
Yew Mun Lee, Weifeng He, Yih‐Cherng Liou
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications
Jin Feng, Xiaohui Wang, Xiaochun Ye, et al.
Pharmacological Research (2022) Vol. 177, pp. 106114-106114
Closed Access | Times Cited: 101
Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in neurons
J. Tabitha Hees, Simone Wanderoy, Jana Lindner, et al.
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 514-530
Open Access | Times Cited: 15
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 2
Pharmacological advances in mitochondrial therapy
Aarti Singh, Danilo Faccenda, Michelangelo Campanella
EBioMedicine (2021) Vol. 65, pp. 103244-103244
Open Access | Times Cited: 88
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Francesca Chiara Pignalosa, Antonella Desiderio, Paola Mirra, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12366-12366
Open Access | Times Cited: 75
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 39
The Molecular Mechanisms Underlying Mitochondria-Associated Endoplasmic Reticulum Membrane-Induced Insulin Resistance
Han Cheng, Xiaokun Gang, Guangyu He, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 63
Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging
Maria Conte, Jacopo Sabbatinelli, Antonio Chiariello, et al.
GeroScience (2020) Vol. 43, Iss. 2, pp. 985-1001
Open Access | Times Cited: 52
Reassessment of Pioglitazone for Alzheimer’s Disease
Ann M. Saunders, Daniel K. Burns, William Gottschalk
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 43
Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
Susana Cardoso, Paula I. Moreira
International review of neurobiology (2020), pp. 37-64
Closed Access | Times Cited: 45
Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis
Fatemeh Karami, Hamidreza Jamaati, Natalie Coleman‐Fuller, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 3, pp. 511-543
Closed Access | Times Cited: 15
Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders
Gretchen A. Johnson, Raghu R. Krishnamoorthy, Dorota L. Stankowska
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 13
Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders
Swapnali Vasant Birajdar, Farhan Mazahir, Md Imtiyaz Alam, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176117-176117
Closed Access | Times Cited: 13
Nonenzymatic function of DPP4 in diabetes‐associated mitochondrial dysfunction and cognitive impairment
Cunwei Sun, Yanhua Xiao, Jiaxiu Li, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 966-987
Closed Access | Times Cited: 32
Reactive Oxygen Species/Reactive Nitrogen Species as Messengers in the Gut: Impact on Physiology and Metabolic Disorders
Anne Abot, Steven G. Fried, Patrice D. Cani, et al.
Antioxidants and Redox Signaling (2021) Vol. 37, Iss. 4-6, pp. 394-415
Closed Access | Times Cited: 31
HDAC6: A Key Link Between Mitochondria and Development of Peripheral Neuropathy
Krystal English, Michelle Barton
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 29
The Mighty Mitochondria Are Unifying Organelles and Metabolic Hubs in Multiple Organs of Obesity, Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes: An Observational Ultrastructure Study
Melvin R. Hayden
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4820-4820
Open Access | Times Cited: 22
Molecular and biochemical mechanisms of diabetic encephalopathy
И. Ф. Беленичев, E. Aliyeva, Olena Popazova, et al.
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 11
Mitochondria-Associated Membranes as Key Regulators in Cellular Homeostasis and the Potential Impact of Exercise on Insulin Resistance
Xi Li, Yangjun Yang, Xiaoyu Shi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3196-3196
Open Access | Times Cited: 4
Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer’s disease rat model
Manickam Rajkumar, Soundarapandian Kannan, Ramasundaram Thangaraj
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2751-2771
Closed Access | Times Cited: 9
Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice
Jasvinder Singh Bhatti, Kavya Tamarai, Ramesh Kandimalla, et al.
Mitochondrion (2021) Vol. 58, pp. 49-58
Closed Access | Times Cited: 21
The p66Shc Redox Protein and the Emerging Complications of Diabetes
Giuseppina Biondi, Nicola Marrano, Anna Borrelli, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 108-108
Open Access | Times Cited: 8
Mitochondria as a target for exercise-mitigated type 2 diabetes
Jingjing Tian, Jingcheng Fan, Tan Zhang
Journal of Molecular Histology (2023) Vol. 54, Iss. 6, pp. 543-557
Closed Access | Times Cited: 7
Antimycin A-induced mitochondrial dysfunction is consistent with impaired insulin signaling in cultured skeletal muscle cells
Sithandiwe E. Mazibuko-Mbeje, Sinenhlanhla X. H. Mthembu, Phiwayinkosi V. Dludla, et al.
Toxicology in Vitro (2021) Vol. 76, pp. 105224-105224
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top